[{"Assets_0_FY_USD":8767415000.0,"CommonStockSharesOutstanding_0_FY_shares":233690816.0,"EarningsPerShareBasic_4_FY_USD":-2.63,"EarningsPerShareDiluted_4_FY_USD":-2.63,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":411050000.0,"NetIncomeLoss_4_FY_USD":-613245000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":2993206000.0,"StockholdersEquity_0_FY_USD":-1243986000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":232785000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":232785000.0,"Ticker":"ENDP","CIK":"1593034","name":"ENDO INTERNATIONAL PLC","OfficialName":"Endo International plc Ordinary Shares","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"640358301.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20220301"}]